Skip to content

Research

All Research Featured Research

Read: Comments to CMS on Proposed Guidance for Coverage with Evidence Development

Comment Letter

Comments to CMS on Proposed Guidance for Coverage with Evidence Development

August 25, 2023

Featured Experts: Alice Chen, PhD, Joseph Grogan, JD, Mireille Jacobson, PhD, Geoffrey Joyce, PhD, Darius Lakdawalla, PhD, Barry Liden, JD, Eugene Lin, MD, MS, Karen Van Nuys, PhD, William Padula, PhD, Alison Sexton Ward, PhD, Julie Zissimopoulos, PhD

Read: Risk Preferences Over Health: Empirical Estimates and Implications for Healthcare Decision-Making

Journal Article

Risk Preferences Over Health: Empirical Estimates and Implications for Healthcare Decision-Making

August 7, 2023

Featured Experts: Karen Mulligan, PhD, Jason Doctor, PhD, Charles E. Phelps, PhD, Darius Lakdawalla, PhD

Read: Four Ways to Make Drug Price Negotiations Work for Everyone

Perspective

Four Ways to Make Drug Price Negotiations Work for Everyone

May 26, 2023

Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD

Read: Testimony on Policies that Inhibit Innovation and Patient Access

Testimony

Testimony on Policies that Inhibit Innovation and Patient Access

May 10, 2023

Featured Experts: Darius Lakdawalla, PhD

Read: A Strategy for Value-Based Drug Pricing Under the Inflation Reduction Act

Perspective

A Strategy for Value-Based Drug Pricing Under the Inflation Reduction Act

May 4, 2023

Featured Experts: Darius Lakdawalla, PhD, Charles E. Phelps, PhD

Read: Alternatives to the QALY for Comparative Effectiveness Research

Perspective

Alternatives to the QALY for Comparative Effectiveness Research

April 21, 2023

Featured Experts: Darius Lakdawalla, PhD, Charles E. Phelps, PhD

Read: Benefits of Medicare Coverage for Weight Loss Drugs

White Paper

Benefits of Medicare Coverage for Weight Loss Drugs

April 18, 2023

Featured Experts: Alison Sexton Ward, PhD, Bryan Tysinger, PhD, PhuongGiang Nguyen, MSPH, Dana Goldman, PhD, Darius Lakdawalla, PhD

Read: Comments to CMS on the Inflation Reduction Act’s Drug Price Negotiation Program

Comment Letter

Comments to CMS on the Inflation Reduction Act’s Drug Price Negotiation Program

April 17, 2023

Featured Experts: Dana Goldman, PhD, Charles E. Phelps, PhD, Darius Lakdawalla, PhD, Joseph Grogan, JD, Karen Van Nuys, PhD, Barry Liden, JD, William Padula, PhD

Read: Mitigating the Inflation Reduction Act’s Adverse Impacts on the Prescription Drug Market

White Paper

Mitigating the Inflation Reduction Act’s Adverse Impacts on the Prescription Drug Market

April 13, 2023

Featured Experts: Dana Goldman, PhD, Joseph Grogan, JD, Darius Lakdawalla, PhD, Barry Liden, JD, Erin Trish, PhD

Read: The Generalized Risk-Adjusted Cost-Effectiveness (GRACE) Model for Measuring the Value of Gains in Health: An Exact Formulation

Journal Article

The Generalized Risk-Adjusted Cost-Effectiveness (GRACE) Model for Measuring the Value of Gains in Health: An Exact Formulation

April 3, 2023

Featured Experts: Darius Lakdawalla, PhD, Charles E. Phelps, PhD

Read: Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part D

Journal Article

Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part D

March 18, 2023

Featured Experts: Darius Lakdawalla, PhD, Neeraj Sood, PhD

Read: Cancer-Related Technologies Have Changed a Lot. So Should Cancer Screening.

White Paper

Cancer-Related Technologies Have Changed a Lot. So Should Cancer Screening.

February 15, 2023

Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD, Karen Van Nuys, PhD

Read: Methods to Adjust Willingness to Pay (WTP) Measures for Severity of Illness

Journal Article

Methods to Adjust Willingness to Pay (WTP) Measures for Severity of Illness

February 14, 2023

Featured Experts: Charles E. Phelps, PhD, Darius Lakdawalla, PhD

Read: Price Changes Varied Widely Across California Hospital Systems from 2012 through 2018

White Paper

Price Changes Varied Widely Across California Hospital Systems from 2012 through 2018

August 18, 2022

Featured Experts: John Romley, PhD, Erin Trish, PhD, Darius Lakdawalla, PhD

Read: Recommendations To Address Key Recruitment Challenges of Alzheimer’s Disease Clinical Trials

Journal Article

Recommendations To Address Key Recruitment Challenges of Alzheimer’s Disease Clinical Trials

August 10, 2022

Featured Experts: Julie Zissimopoulos, PhD, Darius Lakdawalla, PhD, Desi Peneva, MS

Read: Access to Disease-Modifying Alzheimer’s Therapies: Addressing Possible Challenges Using Innovative Payment Models

Journal Article

Access to Disease-Modifying Alzheimer’s Therapies: Addressing Possible Challenges Using Innovative Payment Models

July 5, 2022

Featured Experts: Jakub Hlávka, PhD, Bryan Tysinger, PhD, Darius Lakdawalla, PhD

Read: Comments to the Federal Trade Commission on Pharmacy Benefit Managers

Comment Letter

Comments to the Federal Trade Commission on Pharmacy Benefit Managers

May 25, 2022

Featured Experts: Geoffrey Joyce, PhD, Darius Lakdawalla, PhD, Karen Mulligan, PhD, Neeraj Sood, PhD, Erin Trish, PhD, Karen Van Nuys, PhD

Read: Impact of Non-Binding FDA Guidances On Primary Endpoint Selection in Alzheimer’s Disease Trials

Journal Article

Impact of Non-Binding FDA Guidances On Primary Endpoint Selection in Alzheimer’s Disease Trials

March 24, 2022

Featured Experts: Jakub Hlávka, PhD, Darius Lakdawalla, PhD

Read: Value of Reducing Wait Times for Chimeric Antigen Receptor T-Cell Treatment: Evidence From Randomized Controlled Trial Data on Tisagenlecleucel for Diffuse Large B-Cell Lymphoma

Journal Article

Value of Reducing Wait Times for Chimeric Antigen Receptor T-Cell Treatment: Evidence From Randomized Controlled Trial Data on Tisagenlecleucel for Diffuse Large B-Cell Lymphoma

March 24, 2022

Featured Experts: Alice Chen, PhD, Darius Lakdawalla, PhD

Read: California Should Lead on Health Technology Assessment

Perspective

California Should Lead on Health Technology Assessment

January 27, 2022

Featured Experts: Darius Lakdawalla, PhD, Dana Goldman, PhD

← Previous
1
2
3
4
5
6
7
8
Next →